We are live on ! Find out more
BC

Broadwood Capital Portfolio holdings

AUM $1.91B
1-Year Est. Return 44.39%
This Fund
S&P 500
This Quarter Est. Return
+6.53%
1 Year Est. Return
+44.39%
3 Year Est. Return
+110.36%
5 Year Est. Return
+52.4%
10 Year Est. Return
+1,142.23%
AUM
$517M
AUM Growth
+$34.7M
Cap. Flow
+$17.9M
Cap. Flow %
3.47%
Top 10 Hldgs %
100%
Holding
9
New
–
Increased
3
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
LCTX icon
Lineage Cell Therapeutics
LCTX
+$7.66M
2
AST
Asterias Biotherapeutics Inc. Series A
AST
+$7.44M
3
STAA icon
STAAR Surgical
STAA
+$2.83M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Consumer Staples 49.67%
2 Healthcare 39%
3 Miscellaneous 9.33%
4 Technology 2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MNST icon
1
Monster Beverage
MNST
$87.4B
$257M 49.67%
19,189,632
– –
LCTX icon
2
Lineage Cell Therapeutics
LCTX
$271M
$65M 12.56%
28,457,308
+3,123,403
+12% +$7.66M
STAA icon
3
STAAR Surgical
STAA
$1.12B
$59.8M 11.56%
10,855,179
+437,509
+4% +$2.83M
IWM icon
4
iShares Russell 2000 ETF
IWM
$76.6B
$48.3M 9.33%
420,000
– –
CYNO
5
DELISTED
Cynosure, Inc. Class A
CYNO
$44.6M 8.62%
916,975
– –
MNK
6
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
$19.6M 3.79%
322,411
– –
IMPR
7
DELISTED
IMPRIVATA, INC COM
IMPR
$10.3M 2%
737,911
– –
AST
8
DELISTED
Asterias Biotherapeutics Inc. Series A
AST
$8.88M 1.72%
3,699,848
+2,058,823
+125% +$7.44M
IMDX
9
Insight Molecular Diagnostics
IMDX
$117M
$3.89M 0.75%
54,661
– –

Similar funds

EWS
Evergreen Wealth Solutions Williamsport, Pennsylvania $1.91B AUM 19.99% 1-Year Est. Return
RMA
Roffman Miller Associates Philadelphia, Pennsylvania $1.91B AUM 28.29% 1-Year Est. Return
LWMT
Legacy Wealth Management (Tennessee) Memphis, Tennessee $1.91B AUM 17.42% 1-Year Est. Return
FIB
First Interstate Bank Billings, Montana $1.92B AUM 19.65% 1-Year Est. Return
SAM
Southeastern Asset Management Memphis, Tennessee $1.92B AUM 6.41% 1-Year Est. Return
HPC
Hill Path Capital New York $1.92B AUM 5.67% 1-Year Est. Return
R
Rebalance Palo Alto, California $1.91B AUM 16.23% 1-Year Est. Return
CCIA
Campbell & Co Investment Adviser Baltimore, Maryland $1.91B AUM 17.57% 1-Year Est. Return

Broadwood Capital's Q2 2016 Portfolio in Review

As of Q2 2016, Broadwood Capital held 9 positions worth $517M, up 7.2% from $483M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Broadwood Capital deployed $17.9M of net new capital in Q2 2016, adding to 3 existing holdings.

By sector, the portfolio is most concentrated in Consumer Staples at 50% of assets, up from 44% a quarter earlier, followed by Healthcare and Miscellaneous.

  • Broadwood Capital added most to Lineage Cell Therapeutics in Q2 2016, an estimated $7.66M increase.
  • Broadwood Capital's ten largest holdings make up 100% of its $517M portfolio in Q2 2016.
  • Broadwood Capital opened 0 new positions and closed 0 in Q2 2016.
  • Broadwood Capital's portfolio value rose 7.2% quarter-over-quarter to $517M.

Based on Broadwood Capital's 13F filing for Q2 2016, filed 15 Aug 2016.